Yohei Arihara

机构：Sapporo Medical University, Japanese Foundation For Cancer Research · ORCID：0009-0001-7673-3724

发表论文 97 篇 · 总被引 919 次 · h-index 15

代表论文

Patient characteristics related to screening failure in Phase I trials (2025 · BMC Cancer · 被引 3)
Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial (2025 · Clinical Cancer Research · 被引 2)
SMARCB1-Deficient Malignant Orbital Neoplasm with Features Overlapping Myxoid Epithelioid Sarcoma: A Diagnostic Challenge (2026 · Head and Neck Pathology)
Clinical benefits of early-phase clinical trials for rare malignancies: Asian single-center analysis. (2026 · Journal of Clinical Oncology)
Supplemental Figure 6 from Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial (2026)
Supplemental Figure 4 from Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial (2026)